Positive Phase I data for IMCgp100 in metastatic melanoma
Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC (Immune mobilising monoclonal TCRs Against Cancer), IMCgp100.
Click on this link for more information.
